A Different Approach to Health Plans with HealthWallet’s Ryan Coplon

Healthcare plans are easy when one doesn’t need to use them, but navigating a plan to receive needed care can prove challenging. Ryan Coplon, Co-Founder & President of HealthWallet, believes there is a better way to make order out of the healthcare chaos, and that’s through HealthWallet’s smartphone app. He spoke with Kevin Stevenson about HealthWallet’s unique approach to giving people the healthcare access they desire when they need it.

Coplon’s background comes from the employee benefits and health plan architecture, and that experience shaped his ideas on ways in which a better health plan program could benefit those in need of options. “We realized the more progressive we got with our plan design and infrastructure, the more confused our plan members got,” Coplon said. “So, I saw an opportunity to partner with my co-founder now, in collaboration with the health plan that we managed.” After a year of development, they created an easy platform to drive utilization at the plan level. Once their idea solved these issues, Coplon and his partner recognized the potential to mainstream this idea.

Recent Episodes

In this episode of Inside Restoration & Recovery, host Martha Lewis welcomes Jason McClaren, Director of Facilities Operations at Reunion Rehabilitation Hospitals, to discuss the critical advantage of partnering with a restoration team experienced in healthcare. A former firefighter and military veteran, Jason has spent the last decade managing safety, risk, and emergency preparedness…

In this impactful episode of the ConCensis podcast, host Yasmeen Hassan sits down with Robby Miller, Sterile Processing Manager at St. Joseph’s Hospital Medical Center, to explore how artificial intelligence is revolutionizing the field of sterile processing. With nearly 30 years of experience in healthcare, Miller shares his journey from EMT to SPD leader, offering…

In the last two decades, oncology has undergone a transformation with over 300 new cancer therapies approved by the FDA—many offering novel mechanisms of action. Despite these innovations, resistance to treatment remains a critical challenge, with cancer cells evolving or adapting to evade even the most advanced therapeutics. This issue is particularly pressing given that…